Pacer Advisors, Inc. Alkermes Plc. Transaction History
Pacer Advisors, Inc.
- $39 Billion
- Q2 2024
A detailed history of Pacer Advisors, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 5,640,642 shares of ALKS stock, worth $155 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
5,640,642
Previous 4,278,563
31.83%
Holding current value
$155 Million
Previous $116 Million
17.37%
% of portfolio
0.35%
Previous 0.3%
Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$801 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$551 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$395 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$303 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$254 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.52B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...